REQUEST A DEMO
Total
USD $0.00
Search more companies

Fredun Pharmaceuticals Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Fredun Pharmaceuticals Ltd. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Fredun Pharmaceuticals Ltd. is a pharmaceutical company located in Mumbai, India. With 27 years of experience in manufacturing pharmaceutical formulations, the company has established a reputation as a reliable and ethical organization. Their customer base includes leading pharmaceutical companies in India, as well as buyers across Africa, South East Asia, and CIS countries. The company offers a wide range of products, including analgesics, antacids, anthelmintics, anti-bacterials, anti-diabetics, anti-inflammatory drugs, anti-malarials, anti-obesity drugs, anticoagulants, anticonvulsants, antidiarrheals, antidepressants, antifungals, antihistamines, antihypertensives, antivirals, appetite stimulants with multivitamins, bone modulating drugs, bronchodilators, calcium tablets, cardiovascular drugs, diuretics, impotence drugs, and laxatives. Fredun Pharmaceuticals Ltd. has also expanded into Surgicare Products, offering IV fluids, disposable syringes, IV cannulas, infusion sets, surgical gloves, cottons, and personal healthcare products. They also provide APIs and excipients, ensuring the quality of their products by using the best ingredients available in compliance with regulatory requirements and different pharmacopeia standards. Additionally, the company offers Direct Compressible Granules in various categories such as anti-bacterials, anti-diabetics, analgesics, antihypertensives, antacids, anti-ulcers, anti-emetics, anti-obesity drugs, cardiovascular drugs, cough suppressants, diuretics, impotence drugs, iron supplements, and urology products. Fredun Pharmaceuticals Ltd. is located at 11th Floor, Tower A, Urmi Estate 95, Ganpatrao Kadam Marg, Lower Parel (W), Mumbai 400013. They can be contacted via phone at +91-22-40318111 or fax at +91-22-40318133. Their email address is business@fredungroup.com.

Legal Address
"URMI ESTATE",, 11th Floor, Ganpatrao Kadam Marg
Mumbai; Maharashtra; Postal Code: 400013

Contact Details: Purchase the Fredun Pharmaceuticals Ltd. report to view the information.

Website: http://www.fredungroup.com

Basic Information
Total Employees:
Purchase the Fredun Pharmaceuticals Ltd. report to view the information.
Outstanding Shares:
Purchase the Fredun Pharmaceuticals Ltd. report to view the information.
Registered Capital:
Purchase the Fredun Pharmaceuticals Ltd. report to view the information.
Financial Auditors:
Purchase the Fredun Pharmaceuticals Ltd. report to view the information.
Incorporation Date:
June 08, 1987
Key Executives
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Co. Secretary & Compl. Officer
Purchase this report to view the information.
Ind. Non-Executive Director
Purchase this report to view the information.
Ind. Non-Executive Director
Purchase this report to view the information.
Ind. Non-Executive Director
Ownership Details
Purchase this report to view the information.
48.93%
Purchase this report to view the information.
44.21%
Purchase this report to view the information.
5.27%
Purchase this report to view the information.
1.59%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Fredun Pharmaceuticals Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
26.64%
Total operating revenue
26.64%
Operating profit (EBIT)
39.01%
EBITDA
35.64%
Net Profit (Loss) for the Period
72.08%
Total equity
2.62%
Operating Profit Margin (ROS)
0.94%
Net Profit Margin
1.41%
Return on Equity (ROE)
35.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?